| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Britta Siegmund | Q52911890 |
| P2093 | author name string | Lea I Kredel | |
| P2860 | cites work | High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse | Q21136177 |
| Inflammation and insulin resistance | Q22241893 | ||
| Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature | Q22251115 | ||
| Obesity: Genetic, molecular, and environmental aspects | Q22252954 | ||
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis | Q24629044 | ||
| Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review | Q24801508 | ||
| The origin and definition of brite versus white and classical brown adipocytes | Q27013733 | ||
| Adipose-derived stromal/stem cells: a primer | Q27021721 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study | Q28219755 | ||
| Obesity | Q28275029 | ||
| Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice | Q28730963 | ||
| Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
| Macrophages, inflammation, and insulin resistance | Q29614351 | ||
| Macrophage activation and polarization | Q29616353 | ||
| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 | ||
| Innate lymphoid cells--a proposal for uniform nomenclature | Q29617431 | ||
| Inflammatory mechanisms in obesity | Q29617932 | ||
| National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants | Q29619930 | ||
| Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss | Q38323163 | ||
| A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. | Q38337189 | ||
| CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice | Q39003107 | ||
| Profiling adipocytokine secretion from creeping fat in Crohn's disease | Q40316140 | ||
| The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic | Q40597320 | ||
| Inflamed fat: what starts the fire? | Q40899161 | ||
| Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation | Q41838863 | ||
| Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. | Q41912120 | ||
| PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells | Q42183814 | ||
| Obesity and IBD: are we tipping the scales toward an epidemic? | Q42257916 | ||
| Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. | Q42514705 | ||
| Mesenteric adipose tissue alterations resulting from experimental reactivated colitis | Q42515062 | ||
| Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. | Q42829836 | ||
| Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss | Q43259519 | ||
| Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes | Q43264211 | ||
| Obesity has minimal impact on clinical outcomes in children with inflammatory bowel disease | Q43962815 | ||
| Body weight, gender and response to TNF-α blockers in axial spondyloarthritis | Q44115144 | ||
| Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone | Q44238663 | ||
| Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease | Q44652242 | ||
| Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans | Q44730563 | ||
| Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease. | Q44784148 | ||
| Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. | Q45238657 | ||
| Shades of grey--the blurring view of innate and adaptive immunity | Q45333657 | ||
| Severe and morbid obesity in Crohn's disease patients: prevalence and disease associations. | Q45808148 | ||
| Methotrexate is effective in reactivated colitis and reduces inflammatory alterations in mesenteric adipose tissue during intestinal inflammation. | Q46007130 | ||
| Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease? | Q46379767 | ||
| Eosinophils in fat: pink is the new brown | Q46615563 | ||
| Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients | Q46981453 | ||
| Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters | Q46988914 | ||
| Relationship between adipocyte size and adipokine expression and secretion | Q47310274 | ||
| Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects | Q47402001 | ||
| Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity | Q47861318 | ||
| Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease | Q47990338 | ||
| Group 2 innate lymphoid cells show up in the skin. | Q50898097 | ||
| Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. | Q51497448 | ||
| Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. | Q51891435 | ||
| Mesenteric fat - control site for bacterial translocation in colitis? | Q52888386 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans | Q29622900 | ||
| Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity | Q33724394 | ||
| Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers | Q33813607 | ||
| Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review | Q33870787 | ||
| Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity | Q33930230 | ||
| Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPs | Q33985305 | ||
| Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice | Q34006674 | ||
| Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome | Q34116177 | ||
| Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages | Q34150591 | ||
| Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines | Q34162198 | ||
| Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions | Q34323476 | ||
| Adipose tissue and the immune system | Q34425206 | ||
| Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. | Q34426034 | ||
| Role of adipose tissue as an inflammatory organ in human diseases | Q34523574 | ||
| Evidence for a role of developmental genes in the origin of obesity and body fat distribution | Q34597959 | ||
| Notch signaling pathway activation in normal and hyperglycemic rats differs in the stem cells of visceral and subcutaneous adipose tissue | Q34712757 | ||
| High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity | Q34971829 | ||
| Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 | ||
| Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease | Q35001872 | ||
| Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease | Q35048180 | ||
| Inflammatory cytokine gene expression in mesenteric adipose tissue during acute experimental colitis | Q35080569 | ||
| Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation | Q35083309 | ||
| Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue | Q35147250 | ||
| Inflammatory concepts of obesity | Q35151595 | ||
| Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease | Q35593129 | ||
| Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity | Q35922180 | ||
| Adipose tissue and inflammatory bowel disease pathogenesis | Q36030894 | ||
| CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status | Q36047622 | ||
| Macrophage-mediated inflammation in metabolic disease | Q36060408 | ||
| Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
| Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. | Q36097975 | ||
| Natural killer T cells in adipose tissue prevent insulin resistance | Q36190718 | ||
| Human fat cell lipolysis: biochemistry, regulation and clinical role | Q36324036 | ||
| Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase | Q36377312 | ||
| Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. | Q52938162 | ||
| Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. | Q53078046 | ||
| Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. | Q53556065 | ||
| Modifications of mesenteric adipose tissue during moderate experimental colitis in mice. | Q54236253 | ||
| Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? | Q54348276 | ||
| Is Crohn's creeping fat an adipose tissue? | Q54416901 | ||
| Orchestration of macrophage polarization | Q56942610 | ||
| Body fat distribution and insulin resistance | Q60533965 | ||
| Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice | Q67573165 | ||
| Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues | Q73189940 | ||
| TNFalpha release by the nonfat cells of human adipose tissue | Q75447940 | ||
| Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II | Q77549336 | ||
| Crohn's disease clinical course and severity in obese patients | Q77742629 | ||
| T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity | Q79765934 | ||
| Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots | Q80596917 | ||
| T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance | Q81108550 | ||
| The impact of increased body mass index on the clinical course of Crohn's disease | Q83157629 | ||
| Is obesity a risk factor for Crohn's disease? | Q83164329 | ||
| The obese healthy paradox: is inflammation the answer? | Q84350474 | ||
| Does obesity complicate inflammatory bowel diseases? | Q84456243 | ||
| Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease | Q84595874 | ||
| Comparison of cell proliferation and epigenetic modification of gene expression patterns in canine foetal fibroblasts and adipose tissue-derived mesenchymal stem cells | Q84878398 | ||
| Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. | Q36402697 | ||
| Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications | Q36546700 | ||
| Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers | Q36573719 | ||
| Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? | Q36587155 | ||
| Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages | Q36694157 | ||
| Adipose tissue macrophages. | Q36918994 | ||
| Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes | Q36975445 | ||
| Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes | Q37163809 | ||
| Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. | Q37191048 | ||
| Adipose tissue NK cells manifest an activated phenotype in human obesity | Q37258197 | ||
| Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study | Q37269026 | ||
| Blood spotlight on leukocytes and obesity. | Q37291602 | ||
| Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. | Q37358129 | ||
| Obesity, inflammation, and atherosclerosis | Q37462172 | ||
| Adipokine signaling in inflammatory bowel disease | Q37466469 | ||
| Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding | Q37495662 | ||
| Developmental plasticity of Th17 and Treg cells. | Q37518502 | ||
| Foxp3+ regulatory T cells: differentiation, specification, subphenotypes | Q37523266 | ||
| Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition | Q37544531 | ||
| Subcutaneous and visceral adipose tissue: structural and functional differences | Q37572907 | ||
| What we talk about when we talk about fat. | Q37601812 | ||
| Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity. | Q37704756 | ||
| Defining macrophage phenotype and function in adipose tissue | Q37880478 | ||
| Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism | Q37897011 | ||
| The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment | Q37953988 | ||
| Visceral fat and gut inflammation | Q37972334 | ||
| Adipose tissue-resident immune cells: key players in immunometabolism. | Q38026316 | ||
| Innate lymphoid cells--how did we miss them? | Q38071916 | ||
| Hypoxia and adipose tissue function and dysfunction in obesity. | Q38072900 | ||
| Th1- and Th2-like subsets of innate lymphoid cells | Q38081172 | ||
| The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations | Q38097351 | ||
| Innate and adaptive immunity in inflammatory bowel disease. | Q38115075 | ||
| White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ | Q38182351 | ||
| Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential | Q38183920 | ||
| Distinction of white, beige and brown adipocytes derived from mesenchymal stem cells | Q38190952 | ||
| Adipose invariant natural killer T cells. | Q38199760 | ||
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 462 | |
| P577 | publication date | 2014-09-24 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat | |
| P478 | volume | 5 |
| Q92447007 | Adipocyte Specific HO-1 Gene Therapy is Effective in Antioxidant Treatment of Insulin Resistance and Vascular Function in an Obese Mice Model |
| Q58122569 | Adipokines and Their Role in Intestinal Inflammation |
| Q41107429 | Adipose-derived lipocalin 14 alleviates hyperglycaemia by suppressing both adipocyte glycerol efflux and hepatic gluconeogenesis in mice |
| Q50103146 | Anatomical, Physiological, and Functional Diversity of Adipose Tissue. |
| Q42370720 | Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease? |
| Q36676379 | Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s |
| Q59340042 | Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race |
| Q42376230 | Crohn's Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation. |
| Q46617053 | Effects of Food Additives on Immune Cells As Contributors to Body Weight Gain and Immune-Mediated Metabolic Dysregulation |
| Q42121075 | Exogenous citrate impairs glucose tolerance and promotes visceral adipose tissue inflammation in mice |
| Q36840159 | High-Fat Diet-Induced Obesity Enhances Allograft Rejection |
| Q37054133 | Increased Gustatory Response Score in Obesity and Association Levels with IL-6 and Leptin |
| Q30378828 | Inflammatory insults and mental health consequences: does timing matter when it comes to depression? |
| Q46256007 | Intestinal Ralstonia pickettii augments glucose intolerance in obesity |
| Q91854278 | Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn's disease |
| Q92051810 | Mechanisms Underlying Bone Loss Associated with Gut Inflammation |
| Q49966077 | Obesity and Pancreatic Cancer: Overview of Epidemiology and Potential Prevention by Weight Loss |
| Q30239737 | Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes |
| Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
| Q47272488 | Postoperative excessive gain in visceral adipose tissue as well as body mass index are associated with adverse outcomes of an ileal pouch |
| Q36862870 | Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer |
| Q33588974 | The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial |
| Q28121155 | The mesentery: structure, function, and role in disease |
| Q36305141 | The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease |
Search more.